SEARCH

SEARCH BY CITATION

References

  • Abbott, K.C., Hypolite, I.O. & Agodoa, L.Y. (2002) Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Clinical Nephrology, 58, 915.
  • Alvarez, O., Montane, B., Lopez, G., Wilkinson, J. & Miller, T. (2006) Early blood transfusions protect against microalbuminuria in children with sickle cell disease. Pediatric Blood & Cancer, 47, 7176.
  • Aoki, R.Y. & Saad, S.T. (1995) Enalapril reduces the albuminuria of patients with sickle cell disease. American Journal of Medicine, 98, 432435.
  • Ataga, K.I., Brittain, J.E., Jones, S.K., May, R., Delaney, J., Strayhorn, D., Desai, P., Redding-Lallinger, R., Key, N.S. & Orringer, E.P. (2011) Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell disease. British Journal of Haematology, 152, 485491.
  • Baig, M.A., Lin, Y.S., Rasheed, J. & Mittman, N. (2006) Renal medullary carcinoma. Journal of the National Medical Association, 98, 11711174.
  • Bakanay, S.M., Dainer, E., Clair, B., Adekile, A., Daitch, L., Wells, L., Holley, L., Smith, D. & Kutlar, A. (2005) Mortality in sickle cell patients on hydroxyurea therapy. Blood, 105, 545547.
  • Bakir, A.A., Hathiwala, S.C., Ainis, H., Hryhorczuk, D.O., Rhee, H.L., Levy, P.S. & Dunea, G. (1987) Prognosis of the nephrotic syndrome in sickle glomerulopathy. A retrospective study. American Journal of Nephrology, 7, 110115.
  • Ballas, S.K. (2001) Effect of alpha-globin genotype on the pathophysiology of sickle cell disease. Pediatric Pathology and Molecular Medicine, 20, 107121.
  • Ballas, S.K. & Marcolina, M.J. (2000) Determinants of red cell survival and erythropoietic activity in patients with sickle cell anemia in the steady state. Hemoglobin, 24, 277286.
  • Batlle, D., Itsarayoungyuen, K., Arruda, J.A. & Kurtzman, N.A. (1982) Hyperkalemic hyperchloremic metabolic acidosis in sickle cell hemoglobinopathies. American Journal of Medicine, 72, 188192.
  • Baylis, C. (2008) Nitric oxide deficiency in chronic kidney disease. American Journal of Physiology. Renal Physiology, 294, F1F9.
  • Becton, L.J., Kalpatthi, R.V., Rackoff, E., Disco, D., Orak, J.K., Jackson, S.M. & Shatat, I.F. (2010) Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease. Pediatric Nephrology, 25, 15051511.
  • Bernstein, J. & Whitten, C. (1960) A histological appraisal of the kidney in sickle cell anaemia. Archives of Pathology, 70, 407417.
  • Besarab, A. & Coyne, D.W. (2010) Iron supplementation to treat anemia in patients with chronic kidney disease. Nature Reviews. Nephrology, 6, 699710.
  • Bhatia, M. & Walters, M.C. (2008) Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplantation, 41, 109117.
  • Breen, C.P. & Macdougall, I.C. (1998) Improvement of erythropoietin-resistant anaemia after renal transplantation in patients with homozygous sickle-cell disease. Nephrology, Dialysis, Transplantation, 13, 29492952.
  • Brenner, B.M., Lawler, E.V. & Mackenzie, H.S. (1996) The hyperfiltration theory: a paradigm shift in nephrology. Kidney International, 49, 17741777.
  • Chatterjee, S.N. (1980) National study on natural history of renal allografts in sickle cell disease or trait. Nephron, 25, 199201.
  • Chatterjee, S.N., Lundberg, G.D. & Berne, T.V. (1978) Sickle cell trait: possible contributory cause of renal allograft failure. Urology, 11, 266268.
  • de Jong, P.E. & Statius van Eps, L.W. (1985) Sickle cell nephropathy: new insights into its pathophysiology. Kidney Int, 27, 711717.
  • de Montalembert, M., Brousse, V., Elie, C., Shi, J., Brousse, V. & Landais, P. (2006) Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes. Haematologica, 91, 125128.
  • DeFronzo, R.A., Taufield, P.A., Black, H., McPhedran, P. & Cooke, C.R. (1979) Impaired renal tubular potassium secretion in sickle cell disease. Annals of Internal Medicine, 90, 310316.
  • Di Marco, G.S., Reuter, S., Hillebrand, U., Amler, S., Konig, M., Larger, E., Oberleithner, H., Brand, E., Pavenstadt, H. & Brand, M. (2009) The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD. Journal of the American Society of Nephrology, 20, 22352245.
  • Evans, R.G., Gardiner, B.S., Smith, D.W. & O’Connor, P.M. (2008) Intrarenal oxygenation: unique challenges and the biophysical basis of homeostasis. American Journal of Physiology. Renal Physiology, 295, F1259F1270.
  • Falk, R.J., Scheinman, J., Phillips, G., Orringer, E., Johnson, A. & Jennette, J.C. (1992) Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. New England Journal of Medicine, 326, 910915.
  • Ferster, A., Tahriri, P., Vermylen, C., Sturbois, G., Corazza, F., Fondu, P., Devalck, C., Dresse, M.F., Feremans, W., Hunninck, K., Toppet, M., Philippet, P., Van Geet, C. & Sariban, E. (2001) Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood, 97, 36283632.
  • Fitzhugh, C.D., Wigfall, D.R. & Ware, R.E. (2005) Enalapril and hydroxyurea therapy for children with sickle nephropathy. Pediatric Blood & Cancer, 45, 982985.
  • Freedman, B.I., Hicks, P.J., Bostrom, M.A., Comeau, M.E., Divers, J., Bleyer, A.J., Kopp, J.B., Winkler, C.A., Nelson, G.W., Langefeld, C.D. & Bowden, D.W. (2009a) Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrology, Dialysis, Transplantation, 24, 33663371.
  • Freedman, B.I., Hicks, P.J., Bostrom, M.A., Cunningham, M.E., Liu, Y., Divers, J., Kopp, J.B., Winkler, C.A., Nelson, G.W., Langefeld, C.D. & Bowden, D.W. (2009b) Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney International, 75, 736745.
  • Freedman, B.I., Kopp, J.B., Winkler, C.A., Nelson, G.W., Rao, D.C., Eckfeldt, J.H., Leppert, M.F., Hicks, P.J., Divers, J., Langefeld, C.D. & Hunt, S.C. (2009c) Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study. American Journal of Nephrology, 29, 626632.
  • Genovese, G., Friedman, D.J., Ross, M.D., Lecordier, L., Uzureau, P., Freedman, B.I., Bowden, D.W., Langefeld, C.D., Oleksyk, T.K., Uscinski Knob, A.L., Bernhardy, A.J., Hicks, P.J., Nelson, G.W., Vanhollebeke, B., Winkler, C.A., Kopp, J.B., Pays, E. & Pollak, M.R. (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science, 329, 841845.
  • GISEN (1997) Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet, 349, 18571863.
  • Gordeuk, V.R., Sachdev, V., Taylor, J.G., Gladwin, M.T., Kato, G. & Castro, O.L. (2008) Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency. American Journal of Hematology, 83, 1518.
  • Guasch, A., Cua, M., You, W. & Mitch, W.E. (1997) Sickle cell anemia causes a distinct pattern of glomerular dysfunction. Kidney International, 51, 826833.
  • Guasch, A., Navarrete, J., Nass, K. & Zayas, C.F. (2006) Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure. Journal of the American Society of Nephrology, 17, 22282235.
  • Gurbanov, K., Rubinstein, I., Hoffman, A., Abassi, Z., Better, O.S. & Winaver, J. (1996) Differential regulation of renal regional blood flow by endothelin-1. American Journal of Physiology, 271, F1166F1172.
  • Hankins, J.S., Ware, R.E., Rogers, Z.R., Wynn, L.W., Lane, P.A., Scott, J.P. & Wang, W.C. (2005) Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study. Blood, 106, 22692275.
  • Hatch, F.E., Culbertson, J.W. & Diggs, L.W. (1967) Nature of the renal concentrating defect in sickle cell disease. Journal of Clinical Investigation, 46, 336345.
  • Haymann, J.P., Stankovic, K., Levy, P., Avellino, V., Tharaux, P.L., Letavernier, E., Grateau, G., Baud, L., Girot, R. & Lionnet, F. (2010) Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature. Clinical Journal of the American Society of Nephrology, 5, 756761.
  • Herrera, J., Avila, E., Marin, C. & Rodriguez-Iturbe, B. (2002) Impaired creatinine secretion after an intravenous creatinine load is an early characteristic of the nephropathy of sickle cell anaemia. Nephrology, Dialysis, Transplantation, 17, 602607.
  • Heyman, S.N., Khamaisi, M., Rosen, S. & Rosenberger, C. (2008) Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease. American Journal of Nephrology, 28, 9981006.
  • Horwitz, M.E., Spasojevic, I., Morris, A., Telen, M., Essell, J., Gasparetto, C., Sullivan, K., Long, G., Chute, J., Chao, N. & Rizzieri, D. (2007) Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics. Biology of Blood and Marrow Transplantation, 13, 14221426.
  • Hsieh, M.M., Kang, E.M., Fitzhugh, C.D., Link, M.B., Bolan, C.D., Kurlander, R., Childs, R.W., Rodgers, G.P., Powell, J.D. & Tisdale, J.F. (2009) Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. New England Journal of Medicine, 361, 23092317.
  • Huang, S.H., Sharma, A.P., Yasin, A., Lindsay, R.M., Clark, W.F. & Filler, G. (2011) Hyperfiltration affects accuracy of creatinine eGFR measurement. Clin J Am Soc Nephrol, 6, 274280.
  • Jung, D.C., Kim, S.H., Jung, S.I. & Hwang, S.I. (2006) Renal papillary necrosis: review and comparison of findings at multi-detector row CT and intravenous urography. Radiographics, 26, 18271836.
  • Kato, G.J., Wang, Z., Machado, R.F., Blackwelder, W.C., Taylor, J.G. 6th & Hazen, S.L. (2009) Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death. British Journal of Haematology, 145, 506513.
  • Kim, L., Garfinkel, M.R., Chang, A., Kadambi, P.V. & Meehan, S.M. (2011) Intragraft vascular occlusive sickle crisis with early renal allograft loss in occult sickle cell trait. Human Pathology, 42, 10271033.
  • Kiryluk, K., Jadoon, A., Gupta, M. & Radhakrishnan, J. (2007) Sickle cell trait and gross hematuria. Kidney International, 71, 706710.
  • Kopp, J.B., Winkler, C.A. & Nelson, G.W. (2010) MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing? Seminars in Nephrology, 30, 409417.
  • Little, J.A., McGowan, V.R., Kato, G.J., Partovi, K.S., Feld, J.J., Maric, I., Martyr, S., Taylor, J.G.T., Machado, R.F., Heller, T., Castro, O. & Gladwin, M.T. (2006) Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review. Haematologica, 91, 10761083.
  • Lorenzo, V., Martn, M., Rufino, M., Hernandez, D., Torres, A. & Ayus, J.C. (2004) Predialysis nephrologic care and a functioning arteriovenous fistula at entry are associated with better survival in incident hemodialysis patients: an observational cohort study. American Journal of Kidney Diseases, 43, 9991007.
  • Magee, G.M., Bilous, R.W., Cardwell, C.R., Hunter, S.J., Kee, F. & Fogarty, D.G. (2009) Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia, 52, 691697.
  • Maier-Redelsperger, M., Levy, P., Lionnet, F., Stankovic, K., Haymann, J.P., Lefevre, G., Avellino, V., Perol, J.P., Girot, R. & Elion, J. (2010) Strong association between a new marker of hemolysis and glomerulopathy in sickle cell anemia. Blood Cells, Molecules, and Diseases, 45, 289292.
  • Maigne, G., Ferlicot, S., Galacteros, F., Belenfant, X., Ulinski, T., Niaudet, P., Ronco, P., Godeau, B., Durrbach, A., Sahali, S., Lang, P., Lambotte, O. & Audard, V. (2010) Glomerular lesions in patients with sickle cell disease. Medicine (Baltimore), 89, 1827.
  • Marouf, R., Mojiminiyi, O., Abdella, N., Kortom, M. & Al Wazzan, H. (2006) Comparison of renal function markers in Kuwaiti patients with sickle cell disease. Journal of Clinical Pathology, 59, 345351.
  • McKie, K.T., Hanevold, C.D., Hernandez, C., Waller, J.L., Ortiz, L. & McKie, K.M. (2007) Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease. Journal of Pediatric Hematology/oncology, 29, 140144.
  • Modell, B., Darlison, M., Birgens, H., Cario, H., Faustino, P., Giordano, P.C., Gulbis, B., Hopmeier, P., Lena-Russo, D., Romao, L. & Theodorsson, E. (2007) Epidemiology of haemoglobin disorders in Europe: an overview. Scandinavian Journal of Clinical and Laboratory Investigation, 67, 3969.
  • Nakano, D. & Pollock, D. (2011) New concepts in endothelin control of sodium balance. Clinical and Experimental Pharmacology and Physiology. Epub ahead of print.
  • Nakao, N., Yoshimura, A., Morita, H., Takada, M., Kayano, T. & Ideura, T. (2003) Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet, 361, 117124.
  • Nath, K.A. (2006) Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues. Kidney International, 70, 432443.
  • Nath, K.A., Grande, J.P., Haggard, J.J., Croatt, A.J., Katusic, Z.S., Solovey, A. & Hebbel, R.P. (2001) Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. American Journal of Pathology, 158, 893903.
  • Nolan, V.G., Ma, Q., Cohen, H.T., Adewoye, A., Rybicki, A.C., Baldwin, C., Mahabir, R.N., Homan, E.P., Wyszynski, D.F., Fabry, M.E., Nagel, R.L., Farrer, L.A. & Steinberg, M.H. (2007) Estimated glomerular filtration rate in sickle cell anemia is associated with polymorphisms of bone morphogenetic protein receptor 1B. American Journal of Hematology, 82, 179184.
  • O’Connor, P.M., Kett, M.M., Anderson, W.P. & Evans, R.G. (2006) Renal medullary tissue oxygenation is dependent on both cortical and medullary blood flow. American Journal of Physiology. Renal Physiology, 290, F688F694.
  • Ojo, A.O., Govaerts, T.C., Schmouder, R.L., Leichtman, A.B., Leavey, S.F., Wolfe, R.A., Held, P.J., Port, F.K. & Agodoa, L.Y. (1999) Renal transplantation in end-stage sickle cell nephropathy. Transplantation, 67, 291295.
  • O’Rourke, E.J., Laing, C.M., Khan, A.U., Hussain, R., Standish, R.A., Buscombe, J.R., Hilson, A.J. & Harber, M. (2008) The case. Allograft dysfunction in a patient with sickle cell disease. Kidney International, 74, 12191220.
  • Oster, J.R., Lespier, L.E., Lee, S.M., Pellegrini, E.L. & Vaamonde, C.A. (1976) Renal acidification in sickle-cell disease. Journal of Laboratory and Clinical Medicine, 88, 389401.
  • Palmer Alves, T. & Lewis, J. (2010) Racial differences in chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the United States: a social and economic dilemma. Clinical Nephrology, 74, 7277.
  • Piel, F.B., Patil, A.P., Howes, R.E., Nyangiri, O.A., Gething, P.W., Williams, T.N., Weatherall, D.J. & Hay, S.I. (2010) Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nature Communications, 1, 104.
  • Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H. & Klug, P.P. (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. New England Journal of Medicine, 330, 16391644.
  • Powars, D.R., Elliott-Mills, D.D., Chan, L., Niland, J., Hiti, A.L., Opas, L.M. & Johnson, C. (1991) Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Annals of Internal Medicine, 115, 614620.
  • Powars, D.R., Chan, L.S., Hiti, A., Ramicone, E. & Johnson, C. (2005) Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore), 84, 363376.
  • Quek, L., Sharpe, C., Dutt, N., Height, S., Allman, M., Awogbade, M., Rees, D.C., Zuckerman, M. & Thein, S.L. (2010) Acute human parvovirus B19 infection and nephrotic syndrome in patients with sickle cell disease. British Journal of Haematology, 149, 289291.
  • Ritz, E., Schmieder, R.E. & Pollock, C.A. (2010) Renal protection in diabetes: lessons from ONTARGET. Cardiovascular Diabetology, 9, 60.
  • Roderick, P.J., Raleigh, V.S., Hallam, L. & Mallick, N.P. (1996) The need and demand for renal replacement therapy in ethnic minorities in England. Journal of Epidemiology and Community Health, 50, 334339.
  • Sarnak, M.J., Greene, T., Wang, X., Beck, G., Kusek, J.W., Collins, A.J. & Levey, A.S. (2005) The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Annals of Internal Medicine, 142, 342351.
  • Saxena, A.K., Panhotra, B.R. & Al-Arabi Al-Ghamdi, A.M. (2004a) End-stage sickle cell nephropathy: determinants of reduced survival of patients on long-term hemodialysis. Saudi Journal of Kidney Diseases and Transplantation, 15, 174175.
  • Saxena, A.K., Panhotra, B.R. & Al-Ghamdi, A.M. (2004b) Should early renal transplantation be deemed necessary among patients with end-stage sickle cell nephropathy who are receiving hemodialytic therapy? Transplantation, 77, 955956.
  • Schein, A., Enriquez, C., Coates, T.D. & Wood, J.C. (2008) Magnetic resonance detection of kidney iron deposition in sickle cell disease: a marker of chronic hemolysis. Journal of Magnetic Resonance Imaging, 28, 698704.
  • Scheinman, J.I. (2009) Sickle cell disease and the kidney. Nature Clinical Practice. Nephrology, 5, 7888.
  • Schettler, V. & Wieland, E. (2009) A case report of darbepoetin treatment in a patient with sickle cell disease and chronic renal failure undergoing regular hemodialysis procedures that induce a dose-dependent extension of blood transfusion intervals. Therapeutic Apheresis and Dialysis, 13, 8082.
  • Schmitt, F., Martinez, F., Brillet, G., Giatras, I., Choukroun, G., Girot, R., Bachir, D., Galacteros, F., Lacour, B. & Grunfeld, J.P. (1998) Early glomerular dysfunction in patients with sickle cell anemia. American Journal of Kidney Diseases, 32, 208214.
  • Schrier, R.W., Estacio, R.O., Esler, A. & Mehler, P. (2002) Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International, 61, 10861097.
  • Sebastiani, P., Solovieff, N., Hartley, S.W., Milton, J.N., Riva, A., Dworkis, D.A., Melista, E., Klings, E.S., Garrett, M.E., Telen, M.J., Ashley-Koch, A., Baldwin, C.T. & Steinberg, M.H. (2010) Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study. American Journal of Hematology, 85, 2935.
  • Serjeant, G.R., Serjeant, B.E., Mason, K.P., Hambleton, I.R., Fisher, C. & Higgs, D.R. (2009) The changing face of homozygous sickle cell disease: 102 patients over 60 years. International Journal of Laboratory Hematology, 31, 585596.
  • Statius van Eps, L.W., Schouten, H., La Porte-Wijsman, L.W. & Struyker Boudier, A.M. (1967) The influence of red blood cell transfusions on the hyposthenuria and renal hemodynamics of sickle cell anemia. Clinica Chimica Acta, 17, 449461.
  • Statius van Eps, L.W., Pinedo-Veels, C., de Vries, G.H. & de Koning, J. (1970a) Nature of concentrating defect in sickle-cell nephropathy. Microradioangiographic studies. Lancet, 1, 450452.
  • Statius van Eps, L.W., Schouten, H., Haar Romeny-Wachter, C.C. & La Porte-Wijsman, L.W. (1970b) The relation between age and renal concentrating capacity in sickle cell disease and hemoglobin C disease. Clinica Chimica Acta, 27, 501511.
  • Steinberg, M.H., Barton, F., Castro, O., Pegelow, C.H., Ballas, S.K., Kutlar, A., Orringer, E., Bellevue, R., Olivieri, N., Eckman, J., Varma, M., Ramirez, G., Adler, B., Smith, W., Carlos, T., Ataga, K., DeCastro, L., Bigelow, C., Saunthararajah, Y., Telfer, M., Vichinsky, E., Claster, S., Shurin, S., Bridges, K., Waclawiw, M., Bonds, D. & Terrin, M. (2003) Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA, 289, 16451651.
  • Thein, S.L. (2008) Genetic modifiers of the beta-haemoglobinopathies. British Journal of Haematology, 141, 357366.
  • Thein, S.L. & Menzel, S. (2009) Discovering the genetics underlying foetal haemoglobin production in adults. British Journal of Haematology, 145, 455467.
  • Thompson, J., Reid, M., Hambleton, I. & Serjeant, G.R. (2007) Albuminuria and renal function in homozygous sickle cell disease: observations from a cohort study. Archives of Internal Medicine, 167, 701708.
  • Thornburg, C.D., Dixon, N., Burgett, S., Mortier, N.A., Schultz, W.H., Zimmerman, S.A., Bonner, M., Hardy, K.K., Calatroni, A. & Ware, R.E. (2009) A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia. Pediatric Blood & Cancer, 52, 609615.
  • Voskaridou, E., Terpos, E., Michail, S., Hantzi, E., Anagnostopoulos, A., Margeli, A., Simirloglou, D., Loukopoulos, D. & Papassotiriou, I. (2006) Early markers of renal dysfunction in patients with sickle cell/beta-thalassemia. Kidney International, 69, 20372042.
  • Voskaridou, E., Christoulas, D., Bilalis, A., Plata, E., Varvagiannis, K., Stamatopoulos, G., Sinopoulou, K., Balassopoulou, A., Loukopoulos, D. & Terpos, E. (2010) The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood, 115, 23542363.
  • Walsh, A., Kelly, D.R., Vaid, Y.N., Hilliard, L.M. & Friedman, G.K. (2010) Complete response to carboplatin, gemcitabine, and paclitaxel in a patient with advanced metastatic renal medullary carcinoma. Pediatric Blood & Cancer, 55, 12171220.
  • Wang, W.C., Ware, R.E., Miller, S.T., Iyer, R.V., Casella, J.F., Minniti, C.P., Rana, S., Thornburg, C.D., Rogers, Z.R., Kalpatthi, R.V., Barredo, J.C., Brown, R.C., Sarnaik, S.A., Howard, T.H., Wynn, L.W., Kutlar, A., Armstrong, F.D., Files, B.A., Goldsmith, J.C., Waclawiw, M.A., Huang, X. & Thompson, B.W. (2011) Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet, 377, 16631672.
  • Warady, B.A. & Sullivan, E.K. (1998) Renal transplantation in children with sickle cell disease: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatric Transplantation, 2, 130133.
  • Wesson, D.E. (2002) The initiation and progression of sickle cell nephropathy. Kidney International, 61, 22772286.
  • Wierenga, K.J., Pattison, J.R., Brink, N., Griffiths, M., Miller, M., Shah, D.J., Williams, W., Serjeant, B.E. & Serjeant, G.R. (1995) Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease. Lancet, 346, 475476.
  • Zimmerman, S.A., Schultz, W.H., Davis, J.S., Pickens, C.V., Mortier, N.A., Howard, T.A. & Ware, R.E. (2004) Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. Blood, 103, 20392045.